Literature DB >> 31262856

Potential Molecular Mechanisms of the Anti-cancer Activity of Vitamin D.

Dorota Skrajnowska1, Barbara Bobrowska-Korczak2.   

Abstract

Vitamin D, or more precisely its active metabolite calcitriol (1,25-(OH)2D3), plays a fundamental role in bone metabolism and differentiation as well as in intestinal absorption of calcium and regulation of calcium-phosphate metabolism. Recent decades have brought about the discovery of the role of calcitriol in processes regulating cell differentiation, proliferation, angiogenesis and apoptosis. This creates the potential for numerous therapeutic applications of vitamin D in diseases associated with autoaggressive immune responses or in cancer. This study presents selected issues regarding current knowledge of the anti-cancer mechanisms of vitamin D. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Vitamin D; antitumor effect; nVDR receptor; review

Mesh:

Substances:

Year:  2019        PMID: 31262856     DOI: 10.21873/anticanres.13478

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Vitamin D Receptor Activation Attenuates Hippo Pathway Effectors and Cell Survival in Metastatic Neuroblastoma.

Authors:  Yagnesh Ladumor; Bo Kyung Alex Seong; Robin Hallett; Ivette Valencia-Sama; Teresa Adderley; Yingying Wang; Lynn Kee; Alexander Gont; David R Kaplan; Meredith S Irwin
Journal:  Mol Cancer Res       Date:  2022-06-03       Impact factor: 6.333

Review 2.  Vitamin D in physiological and pathological aging: Lesson from centenarians.

Authors:  Evelyn Ferri; Martina Casati; Matteo Cesari; Giovanni Vitale; Beatrice Arosio
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

Review 3.  Newly-identified Pathways Relating Vitamin D to Carcinogenesis: A Review.

Authors:  Nadeem Bilani; Leah Elson; Charles Szuchan; Elizabeth Elimimian; Mustafa Saleh; Zeina Nahleh
Journal:  In Vivo       Date:  2021-04-28       Impact factor: 2.406

4.  Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3.

Authors:  Zixian Huang; Yin Zhang; Haigang Li; Yufeng Zhou; Qianyu Zhang; Rui Chen; Tingting Jin; Kaishun Hu; Shihao Li; Yan Wang; Weiliang Chen; Zhiquan Huang
Journal:  Cell Death Dis       Date:  2019-12-09       Impact factor: 8.469

Review 5.  Vitamin D, gut microbiota, and radiation-related resistance: a love-hate triangle.

Authors:  Ruixue Huang; Jing Xiang; Pingkun Zhou
Journal:  J Exp Clin Cancer Res       Date:  2019-12-16

6.  Assessment the effect of vitamin D supplementation on plasma vitamin D levels, inflammation, and oxidative stress biomarkers based on vitamin D receptor genetic variation in breast cancer survivors: a protocol for clinical trial.

Authors:  Elham Kazemian; Mohammad Esmaeil Akbari; Nariman Moradi; Safoora Gharibzadeh; Atieh Amouzegar; Laura S Rozek; Alison M Mondul; Maryam Khademolmele; Katie R Zarins; Nasim Ghodoosi; Zahra Shateri; Soudabeh Fallah; Sayed Hossein Davoodi
Journal:  J Health Popul Nutr       Date:  2021-11-02       Impact factor: 2.000

7.  Effect Modification of Vitamin D Supplementation by Histopathological Characteristics on Survival of Patients with Digestive Tract Cancer: Post Hoc Analysis of the AMATERASU Randomized Clinical Trial.

Authors:  Hideyuki Yonaga; Shinya Okada; Taisuke Akutsu; Hironori Ohdaira; Yutaka Suzuki; Mitsuyoshi Urashima
Journal:  Nutrients       Date:  2019-10-22       Impact factor: 5.717

8.  Vitamin D receptor knockdown attenuates the antiproliferative, pro‑apoptotic and anti‑invasive effect of vitamin D by activating the Wnt/β‑catenin signaling pathway in papillary thyroid cancer.

Authors:  Rui Pang; Ye Xu; Xiaonan Hu; Bo Liu; Jiawei Yu
Journal:  Mol Med Rep       Date:  2020-09-17       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.